毛细胞白血病患者的可逆性心肌病。 - Suppr

Suppr

超能文献

Reversible cardiomyopathy in a patient with hairy cell leukaemia.

作者信息

Sucak G T, Haznedar R, Yalçin R

机构信息

Department of Hematology, Gazi University Medical School, Ankara, Turkey.

出版信息

Postgrad Med J. 1998 May;74(871):313-4. doi: 10.1136/pgmj.74.871.313.

DOI:10.1136/pgmj.74.871.313

PMID:9713625

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360904/

Abstract

摘要

相似文献

Reversible cardiomyopathy in a patient with hairy cell leukaemia.毛细胞白血病患者的可逆性心肌病。

Postgrad Med J. 1998 May;74(871):313-4. doi: 10.1136/pgmj.74.871.313.

Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.干扰素-α治疗毛细胞白血病后发生的急性髓系白血病。

Br J Haematol. 1993 Mar;83(3):519-20. doi: 10.1111/j.1365-2141.1993.tb04680.x.

Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia.

Ren Fail. 1993;15(4):559-61. doi: 10.3109/08860229309054974.

[Immunoblastic lymphoma following hairy cell leukemia treated with interferon alpha-2a].

Ann Med Interne (Paris). 1996;147(3):221-2.

Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.α干扰素治疗后毛细胞白血病中的红细胞增多症。

Br J Haematol. 1990 May;75(1):133-5. doi: 10.1111/j.1365-2141.1990.tb02630.x.

Therapeutic advances in the treatment of hairy cell leukemia.

Leuk Res. 2001 May;25(5):361-8. doi: 10.1016/s0145-2126(00)00090-4.

Interferon in the treatment of hairy-cell leukemia.

Best Pract Res Clin Haematol. 2003 Mar;16(1):69-81. doi: 10.1016/s1521-6926(02)00084-1.

Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia.干扰素-α治疗毛细胞白血病后发生胰岛素依赖型糖尿病。

Lancet. 1994 May 7;343(8906):1167-8. doi: 10.1016/s0140-6736(94)90276-3.

Regression of diffuse osteosclerosis in hairy cell leukaemia after treatment with interferon.干扰素治疗后毛细胞白血病弥漫性骨硬化的消退

Br J Haematol. 1990 Sep;76(1):150-1. doi: 10.1111/j.1365-2141.1990.tb07853.x.

Interferon alfa-2a.

Br J Hosp Med. 1997;57(9):436-9.

引用本文的文献

Rare Clinical Symptoms in Hairy Cell Leukemia: An Overview.毛细胞白血病的罕见临床症状：概述

Cancers (Basel). 2024 Sep 1;16(17):3054. doi: 10.3390/cancers16173054.

本文引用的文献

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication.心脏毒性作为大剂量推注白细胞介素-2和α-干扰素治疗方案中的剂量限制因素。一种出人意料的常见并发症。

Cancer. 1994 Nov 15;74(10):2850-6. doi: 10.1002/1097-0142(19941115)74:10<2850::aid-cncr2820741018>3.0.co;2-t.

Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.重组干扰素α-2a（罗扰素）在癌症患者中的安全性和耐受性。

Cancer. 1986 Apr 15;57(8 Suppl):1709-15. doi: 10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f.

Recombinant alpha 2 interferon-related cardiomyopathy.重组α2干扰素相关性心肌病

Am J Med. 1988 Oct;85(4):549-51. doi: 10.1016/s0002-9343(88)80094-9.

Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma.患有卡波西肉瘤的艾滋病患者接受干扰素α治疗后出现的可逆性心脏功能障碍。

N Engl J Med. 1989 Nov 2;321(18):1246-9. doi: 10.1056/NEJM198911023211806.

Reversible cardiomyopathy induced by interferon.

BMJ. 1990 May 5;300(6733):1174-5. doi: 10.1136/bmj.300.6733.1174.

Cardiotoxicity of interferon. A review of 44 cases.干扰素的心脏毒性。44例病例回顾。

Chest. 1991 Mar;99(3):557-61. doi: 10.1378/chest.99.3.557.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验